FDA Recall D-1504-2020

Ferring Pharmaceuticals Inc · Parsippany, NJ

Class I — life-threatening Terminated 1179 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0

Lot / code: Lot #: N14695F, exp. date 08/2020 N15627C, exp. date 10/2020 P11319P, exp. date 01/2021 P11706F, exp. date 04/2021 R11842C, exp. date 03/2022; R13637E, exp. date 06/2022

Quantity: 15,175 nasal sprays

Reason for recall

Superpotent Drug

Recall record

Recall number: D-1504-2020
Classification: Class I
Status: Terminated
Voluntary or mandated: Voluntary: Firm initiated
Firm notification: Letter
Distribution: Nationwide within the United States.
Recall initiated: 2020-07-21
Classified by FDA Center: 2020-08-17
FDA published: 2020-08-26
Terminated: 2023-10-13
Recalling firm: Ferring Pharmaceuticals Inc
Firm location: Parsippany, NJ

‹ All recalls